Work

Phase 2 trial of brentuximab vedotin and gemcitabine for pediatric and young adult patients with relapsed or refractory Hodgkin lymphoma (HL): A Children’s Oncology Group (COG) report.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.7527

Authors: Peter D. Cole, Kathleen McCarten, Monika Metzger, Richard A. Drachtman, Terzah M. Horton, Qinglin Pei, Rizvan Bush, Susan Blaney, Brenda Weigel, Kara M. Kelly

Institutions: Children's Hospital at Montefiore, Rhode Island Hospital, St. Jude Children's Research Hospital, Rutgers Cancer Institute, Baylor College of Medicine, Children's Oncology Group, University of Minnesota, Roswell Park Comprehensive Cancer Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2890530869

Cites:

Cited by: 5

Related to: 10